NIVOLUMAB + RELATLIMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13817FMP | NIVOLUMAB + RELATLIMAB nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial (PI, CMI) |
2 | 2 | 11 | $18195.80 | $31.60 | $31.60 |
Available brands | |||||||
Opdualag |
- Legend
- MPMedical Practitioner